497 1 ntl-497e.htm T. ROWE - NATIONAL SUPPLEMENT TO PEA #10 & 11 T. Rowe Price Supplement
T. ROWE PRICE NO-LOAD VARIABLE ANNUITY
--------------------------------------------------------------------------------
An Individual Flexible Premium Deferred Variable Annuity Contract


Supplement Dated February 1, 2001, to Prospectus Dated May 1, 2000
--------------------------------------------------------------------------------

ISSUED BY:                         MAILING ADDRESS:
Security Benefit                   T. Rowe Price Variable
Life Insurance Company             Annuity Service Center
700 SW Harrison Street             P.O. Box 750440
Topeka, Kansas 66636-0001          Topeka, Kansas 66675-0440
1-800-888-2461                     1-800-469-6587


The Prospectus is supplemented to reflect three new Subaccounts  available under
the Contract,  effective  February 1, 2001. The new  Subaccounts are as follows:
Blue Chip  Growth;  Health  Sciences;  and  Equity  Index  500.  Each of the new
Subaccounts  invests in a  corresponding  Portfolio  of the T. Rowe Price Equity
Series, Inc.

The  following  information  is added under the  heading,  "T. Rowe Price Equity
Series, Inc.," under the section, "Introduction," page 2:

   T. Rowe Price Blue Chip Growth Portfolio
   T. Rowe Price Health Sciences Portfolio
   T. Rowe Price Equity Index 500 Portfolio

The  following  information  is added under the  heading,  "T. Rowe Price Equity
Series, Inc.," under the subsection,  "The Separate Account and the Funds," page
7:

   T. Rowe Price Blue Chip Growth Portfolio
   T. Rowe Price Health Sciences Portfolio
   T. Rowe Price Equity Index 500 Portfolio

The  following  information  is  added to Table 1 under  the  section,  "Expense
Table," page 9:

   -----------------------------------------------------------------------------
                                                                         TOTAL
                                               MANAGEMENT    OTHER     PORTFOLIO
                                                  FEE(1)    EXPENSES   EXPENSES
   T. Rowe Price Blue Chip Growth Portfolio       .85%         0%        .85%
   T. Rowe Price Health Sciences Portfolio        .95%         0%        .95%
   T. Rowe Price Equity Index 500 Portfolio       .40%         0%        .40%
   -----------------------------------------------------------------------------

The following information is added to the "Example," page 10:

   -----------------------------------------------------------------------------
                                     1 YEAR     3 YEARS     5 YEARS     10 YEARS
   Blue Chip Growth Subaccount        $14         $44         $77         $168
   Health Sciences Subaccount         $15         $47         $82         $179
   Equity Index 500 Subaccount        $10         $30         $53         $117
   -----------------------------------------------------------------------------

The  following  summary of each new  Portfolio's  investment  objective is added
under the subsection, "The Funds," page 13:

   T. ROWE PRICE BLUE CHIP GROWTH PORTFOLIO

   The  investment  objective of the Blue Chip Growth  Portfolio is to seek long
   term capital  growth by investing  primarily in common stocks of high quality
   U.S. growth companies. Income is a secondary objective.

   T. ROWE PRICE HEALTH SCIENCES PORTFOLIO

   The  investment  objective of the Health  Sciences  Portfolio is to seek long
   term  capital  appreciation  by investing  primarily in the common  stocks of
   companies engaged in the research, development, production or distribution of
   products or services related to health care, medicine, or the life sciences.

   T. ROWE PRICE EQUITY INDEX 500 PORTFOLIO*

   The  investment  objective of the Equity Index 500  Portfolio is to match the
   performance of the Standard & Poor's 500 Stock Index(R).  The S&P 500 is made
   up of  primarily  large  capitalization  companies  that  represent  a  broad
   spectrum  of the  U.S.  economy  and a  substantial  part of the  U.S.  stock
   market's total capitalization.

   *"Standard & Poor's," "S&P," "S&P 500," "Standard & Poor's 500" and "500" are
    trademarks of the McGraw-Hill Companies, Inc. and have been licensed for use
    by T. Rowe Price. The Portfolio is not sponsored, endorsed, sold or promoted
    by Standard & Poor's and Standard & Poor's makes no representation regarding
    the advisability of investing in the Portfolio.

The subsection,  "The Investment  Advisers," page 14, is deleted in its entirety
and replaced with the following:

THE INVESTMENT ADVISERS

   T. Rowe Price Associates,  Inc. ("T. Rowe Price"),  located at 100 East Pratt
   Street,  Baltimore,  Maryland  21202,  serves as  Investment  Adviser to each
   Portfolio,  except the T. Rowe Price International  Stock Portfolio.  T. Rowe
   Price  International,  Inc.  ("TRP  International"),  an affiliate of T. Rowe
   Price,  serves as Investment Adviser to the T. Rowe Price International Stock
   Portfolio.  TRP  International's  U.S.  office is  located  at 100 East Pratt
   Street, Baltimore, Maryland 21202. T. Rowe Price is responsible for selection
   and management of portfolio investments for each Portfolio except the T. Rowe
   Price International Stock Portfolio, and TRP International is responsible for
   selection and management of portfolio investments for that Portfolio. T. Rowe
   Price  and TRP  International  are  registered  with  the  SEC as  investment
   advisers.

   T. Rowe Price and TRP International are not affiliated with the Company,  and
   the Company has no  responsibility  for the  management  or operations of the
   Portfolios.

The second sentence in the subsection,  "Distribution of the Contract," page 40,
is deleted in its entirety and replaced with the following:

   Investment  Services  also acts as the  distributor  of certain  mutual funds
   advised by T. Rowe Price and TRP International.

T. ROWE PRICE NO-LOAD IMMEDIATE VARIABLE ANNUITY
--------------------------------------------------------------------------------
An Individual Single Premium Immediate Variable Annuity Contract


Supplement Dated February 1, 2001, to Prospectus Dated May 1, 2000
--------------------------------------------------------------------------------

ISSUED BY:                         MAILING ADDRESS:
Security Benefit                   T. Rowe Price Variable
Life Insurance Company             Annuity Service Center
700 SW Harrison Street             P.O. Box 750440
Topeka, Kansas 66636-0001          Topeka, Kansas 66675-0440
1-800-888-2461                     1-800-469-6587

The Prospectus is supplemented to reflect three new Subaccounts  available under
the Contract,  effective  February 1, 2001. The new  Subaccounts are as follows:
Blue Chip  Growth;  Health  Sciences;  and  Equity  Index  500.  Each of the new
Subaccounts  invests in a  corresponding  Portfolio  of the T. Rowe Price Equity
Series, Inc.

The  following  information  is added under the  heading,  "T. Rowe Price Equity
Series,  Inc.," under the "Introduction,"  page 2, and "The Separate Account and
the Funds," page 7:

   T. Rowe Price Blue Chip Growth Portfolio
   T. Rowe Price Health Sciences Portfolio
   T. Rowe Price Equity Index 500 Portfolio

The  following  information  is  added to Table 1 under  the  section,  "Expense
Table," page 9:

   -----------------------------------------------------------------------------
                                                                         TOTAL
                                               MANAGEMENT    OTHER     PORTFOLIO
                                                 FEE(1)     EXPENSES   EXPENSES
   T. Rowe Price Blue Chip Growth Portfolio       .85%         0%        .85%
   T. Rowe Price Health Sciences Portfolio        .95%         0%        .95%
   T. Rowe Price Equity Index 500 Portfolio       .40%         0%        .40%
   -----------------------------------------------------------------------------

The following new  information is added to the respective  "Examples,"  found on
pages 10 and 11:

   EXAMPLE  - You would  pay the  expenses  shown  below  (unless  Option 9 were
   selected):

   -----------------------------------------------------------------------------
                                     1 YEAR     3 YEARS     5 YEARS     10 YEARS
   Blue Chip Growth Subaccount        $14         $44         $77         $168
   Health Sciences Subaccount         $15         $47         $82         $179
   Equity Index 500 Subaccount        $10         $30         $53         $117
   -----------------------------------------------------------------------------

   EXAMPLE - You would pay the expenses  shown below  assuming (1)  selection of
   Option 9, and (2) no withdrawals:

   -----------------------------------------------------------------------------
                                     1 YEAR     3 YEARS     5 YEARS     10 YEARS
   Blue Chip Growth Subaccount        $23         $70        $120         $258
   Health Sciences Subaccount         $24         $73        $126         $269
   Equity Index 500 Subaccount        $18         $57         $97         $212
   -----------------------------------------------------------------------------

   EXAMPLE - You would pay the expenses  shown below  assuming (1)  selection of
   Option 9, and (2) a full withdrawal at the end of each time period:

   -----------------------------------------------------------------------------
                                   1 YEAR     3 YEARS     5 YEARS     10 YEARS**
   Blue Chip Growth Subaccount      $74         $103       $132          $258
   Health Sciences Subaccount       $75         $106       $137          $269
   Equity Index 500 Subaccount      $70         $90        $109          $212
   -----------------------------------------------------------------------------

The following information is added under the subsection, "The Funds," page 14:

   T. ROWE PRICE BLUE CHIP GROWTH PORTFOLIO

   The  investment  objective of the Blue Chip Growth  Portfolio is to seek long
   term capital  growth by investing  primarily in common stocks of high quality
   U.S. growth companies. Income is a secondary objective.

   T. ROWE PRICE HEALTH SCIENCES PORTFOLIO

   The  investment  objective of the Health  Sciences  Portfolio is to seek long
   term  capital  appreciation  by investing  primarily in the common  stocks of
   companies engaged in the research, development, production or distribution of
   products or services related to health care, medicine, or the life sciences.

   T. ROWE PRICE EQUITY INDEX 500 PORTFOLIO*

   The  investment  objective of the Equity Index 500  Portfolio is to match the
   performance of the Standard & Poor's 500 Stock Index(R).  The S&P 500 is made
   up of  primarily  large  capitalization  companies  that  represent  a  broad
   spectrum  of the  U.S.  economy  and a  substantial  part of the  U.S.  stock
   market's total capitalization.

   *"Standard & Poor's," "S&P," "S&P 500," "Standard & Poor's 500" and "500" are
    trademarks of the McGraw-Hill Companies, Inc. and have been licensed for use
    by T. Rowe Price. The Portfolio is not sponsored, endorsed, sold or promoted
    by Standard & Poor's and Standard & Poor's makes no representation regarding
    the advisability of investing in the Portfolio.

The subsection,  "The Investment  Advisers," page 15, is deleted in its entirety
and replaced with the following:

THE INVESTMENT ADVISERS

   T. Rowe Price Associates,  Inc. ("T. Rowe Price"),  located at 100 East Pratt
   Street,  Baltimore,  Maryland  21202,  serves as  Investment  Adviser to each
   Portfolio,  except the T. Rowe Price International  Stock Portfolio.  T. Rowe
   Price  International,  Inc.  ("TRP  International"),  an affiliate of T. Rowe
   Price,  serves as Investment Adviser to the T. Rowe Price International Stock
   Portfolio.  TRP  International's  U.S.  office is  located  at 100 East Pratt
   Street, Baltimore, Maryland 21202. T. Rowe Price is responsible for selection
   and management of portfolio investments for each Portfolio except the T. Rowe
   Price International Stock Portfolio, and TRP International is responsible for
   selection and management of portfolio investments for that Portfolio. T. Rowe
   Price  and TRP  International  are  registered  with  the  SEC as  investment
   advisers.

   T. Rowe Price and TRP International are not affiliated with the Company,  and
   the Company has no  responsibility  for the  management  or operations of the
   Portfolios.

The second sentence in the subsection,  "Distribution of the Contract," page 39,
is deleted in its entirety and replaced with the following:

   Investment  Services  also acts as the  distributor  of certain  mutual funds
   advised by T. Rowe Price and TRP International.